Skip to main content
. 2018 Feb 1;7(5):e1424674. doi: 10.1080/2162402X.2018.1424674

Table 3.

Clinical outcomes stratified by occurrence of anti-drug antibodies.

  OS
PFS
  Median (range) HR (95% CI) p Median (range) HR (95% CI) p
ADA-positive 235 (67-927) 3.0 (1.2-7.8) 0.03 80 (34-476) 2.1 (0.9-5.0) 0.08
ADA-negative 658 (62-1365)     191 (55-1224)    

Hazard ratios and p-values were calculated using Cox proportional hazards regression model. PFS: Progression-free survival (days); OS: Overall survival (days); HR: Hazard ratio; CI: Confidence interval.